Towards global consensus on outcome measures for atopic eczema research: Results of the HOME II meeting

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 9, 2012, Pages 1111-1117

  Schmitt, Jochen ^a,b   Spuls, Phyllis ^c   Boers, Maarten ^d   Thomas, Kim ^e   Chalmers, Joanne ^e   Roekevisch, Evelien ^c   Schram, Mandy ^c   Allsopp, Richard ^f   Aoki, Valeria ^g   Apfelbacher, Christian ^h,i   Bruijnzeel Koomen, Carla ^j   Bruin Weller, Marjolein ^j   Charman, Carolyn ^k   Cohen, Arnon ^l   Dohil, Magdalene ^m   Flohr, Carsten ^n,o   Furue, Masutaka ^p   Gieler, Uwe ^q   Hooft, Lotty ^c   Humphreys, Rosemary ^r   Ishii, Henrique Akira ^g   Katayama, Ichiro ^s   Kouwenhoven, Willem ^t   Langan, Sinéad ^n,u   Lewis Jones, Sue ^v   Merhand, Stephanie ^w   Murota, Hiroyuki ^s   Murrell, Dedee F ^x,y   Nankervis, Helen ^e   Ohya, Yukihiro ^z   Oranje, Arnold ^aa   Otsuka, Hiromi ^ab   Paul, Carle ^ac   Rosenbluth, Yael ^l   Saeki, Hidehisa ^ad   Schuttelaar, Marie Louise ^ae   Stalder, Jean Francois ^af   Svensson, Ãke ^ag   Takaoka, Roberto ^g   Wahlgren, Carl Fredrik ^ah   Weidinger, Stephan ^ai   Wollenberg, Andreas ^aj   Williams, Hywel ^e,ak   more..

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f ASTELLAS PHARMA EUROPE LTD   (United Kingdom)

^g UNIVERSITY OF SÃO PAULO   (Brazil)

^h UNIVERSITY OF REGENSBURG   (Germany)

ⁱ UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^j UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^k ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^l CLALIT HEALTH SERVICES   (Israel)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^o KING'S COLLEGE LONDON   (United Kingdom)

^p KYUSHU UNIVERSITY   (Japan)

^q JUSTUS LIEBIG UNIVERSITY   (Germany)

^r NATIONAL ECZEMA SOCIETY   (United Kingdom)

^s OSAKA UNIVERSITY   (Japan)

^t Dutch Consumers Organisation VMCE   (Netherlands)

^u LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^v UNIVERSITY OF DUNDEE   (United Kingdom)

^w French Association of Eczema   (France)

^x ST GEORGE HOSPITAL   (Australia)

^y UNIVERSITY OF NEW SOUTH WALES   (Australia)

^z NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^aa SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^ab Japan Allergy Volunteer Association   (Japan)

^ac SERVICE DE PNEUMOLOGIE   (France)

^ad JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^ae UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^af NANTES UNIVERSITY HOSPITAL   (France)

^ag LUND UNIVERSITY HOSPITAL   (Sweden)

^ah KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^ai UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^aj UNIVERSITY OF MUNICH   (Germany)

^ak NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

more..

Author keywords

atopic dermatitis; consensus study; measurement; outcome domain; study endpoint

Indexed keywords

ATOPIC DERMATITIS; CONFERENCE PAPER; CONSENSUS; CONSENSUS DEVELOPMENT; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; INTERNATIONAL COOPERATION; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL;

CLINICAL TRIALS AS TOPIC; DERMATITIS, ATOPIC; FEMALE; HUMANS; INTERNATIONAL COOPERATION; MALE; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84864977670     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2012.02874.x     Document Type: Conference Paper

References (27)

1. Lewis-Jones S,. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract 2006; 60: 984-992.
2. Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB Jr, Manuel JC,. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 2005; 22: 192-199.
3. Williams HC,. Epidemiology of atopic dermatitis. Clin Exp Dermatol 2000; 25: 522-529.
4. Schmitt J, Schmitt NM, Kirch W, Meurer M,. Outpatient care and medical treatment of children and adults with atopic eczema. J Dtsch Dermatol Ges 2009; 7: 345-351.
5. Bieber T,. Atopic dermatitis. N Engl J Med 2008; 358: 1483-1494.
6. Williams HC, Burney PG, Hay RJ, Archer CB, Shipley MJ, Hunter JJ, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol 1994; 131: 383-396.
7. Smaldone A, Honig JC, Byrne MW,. Sleepless in America: inadequate sleep and relationships to health and well-being of our nation's children. Pediatrics 2007; 119 (Suppl 1): S29-S37.
8. Tugwell P, Boers M,. Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. OMERACT Committee. J Rheumatol 1993; 20: 555-556.
9. Tugwell P, Boers M, Brooks P, Simon L, Strand V, Idzerda L,. OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials 2007; 8: 38.
10. Boers M, Brooks P, Strand CV, Tugwell P,. The OMERACT filter for outcome measures in rheumatology. J Rheumatol 1998; 25: 198-199.
11. Schmitt J, Langan SM, Williams HC,. What are the best outcome measurements for atopic eczema? A systematic review J Allergy Clin Immunol 2007; 120: 1389-1398.
12. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186: 23-31.
13. Tofte SJ, Graeber M, Cherill R, Omoto M, Thurston M, Hanifin JM,. Eczema area and severity index (EASI): a new tool to evaluate atopic dermatitis. J Eur Acad Dermatol Venereol 1998; 11 (Suppl 2): S197.
14. Charman CR, Venn AJ, Williams HC,. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Arch Dermatol 2004; 140: 1513-1519.
15. Schmitt J, von Kobyletzki L, Svensson A, Apfelbacher C,. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin-inhibitors for atopic eczema: systematic review and meta-analysis of randomised controlled trials. Br J Dermatol 2011; 164: 415-428.
16. Langan SM, Thomas KS, Williams HC,. What is meant by a "flare" in atopic dermatitis? A systematic review and proposal. Arch Dermatol 2006; 142: 1190-1196.
17. Schmitt J, Langan S, Stamm T, Williams HC,. Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective delphi consensus process. J Invest Dermatol 2011; 131: 623-630.
18. Schmitt J, Williams HC,. Harmonising Outcome Measures for Eczema (HOME). Report from the first international consensus meeting (HOME 1), 24 July 2010, Munich, Germany. Br J Dermatol 2010; 163: 1166-1168.
19. Tugwell P, Boers M,. OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction. J Rheumatol 1993; 20: 528-530.
20. Berth-Jones J,. Six area, six sign atopic dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996; 135 (Suppl 48): 25-30.
21. Wolkerstorfer A, de Waard van der Spek FB, Glazenburg EJ, Mulder PGH, Oranje AP,. Scoring the severity of atopic dermatitis: three item severity score as a rough system for daily practice and as a pre-screening tool for studies. Acta Derm Venereol 1999; 79: 356-359.
22. Schram ME, Spuls PI, Leeflang MM, Lindeboom R, Bos JD, Schmitt J,. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy 2012; 67: 99-106.
23. Tremp M, Knafla I, Burg G, Wuthrich B, Schmid-Grendelmeier P,. 'EASIdig'-a digital tool to document disease activity in atopic dermatitis. Dermatology 2011; 223: 68-73.
24. Charman C, Chambers C, Williams H,. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? J Invest Dermatol 2003; 120: 932-941.
25. Charman C, Williams H,. Outcome measures of disease severity in atopic eczema. Arch Dermatol 2000; 136: 763-769.
26. Charman CR, Venn AJ, Williams HC,. Measurement of body surface area involvement in atopic eczema: an impossible task? Br J Dermatol 1999; 140: 109-111.
27. Williamson P, Blazeby J, Altman D, Clarke M,. BMJ blog: The Comet initiative. http://blogs-bmj-com/bmj/2010/03/08/the-comet-initiative/.